142 related articles for article (PubMed ID: 27014847)
21. Pharmacokinetic disposition of the oral iron chelator deferiprone in the white leghorn chicken.
Whiteside DP; Barker IK; Conlon PD; Tesoro A; Thiessen JJ; Mehren KG; Jacobs RM; Spino M
J Avian Med Surg; 2007 Jun; 21(2):110-20. PubMed ID: 18065132
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of 2-amido-3-hydroxypyridin-4(1H)-ones: novel iron chelators with enhanced pFe3+ values.
Liu ZD; Piyamongkol S; Liu DY; Khodr HH; Lu SL; Hider RC
Bioorg Med Chem; 2001 Mar; 9(3):563-73. PubMed ID: 11310590
[TBL] [Abstract][Full Text] [Related]
23. Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapy.
Devanur LD; Evans RW; Evans PJ; Hider RC
Biochem J; 2008 Jan; 409(2):439-47. PubMed ID: 17919118
[TBL] [Abstract][Full Text] [Related]
24. PCTH: a novel orally active chelator of the aroylhydrazone class that induces iron excretion from mice.
Wong CS; Kwok JC; Richardson DR
Biochim Biophys Acta; 2004 Dec; 1739(1):70-80. PubMed ID: 15607119
[TBL] [Abstract][Full Text] [Related]
25. Deferiprone: second-line treatment of iron overload in the absence of a better alternative.
Prescrire Int; 2007 Oct; 16(91):196. PubMed ID: 17926834
[TBL] [Abstract][Full Text] [Related]
26. Amido-3-hydroxypyridin-4-ones as iron(III) ligands.
Piyamongkol S; Ma YM; Kong XL; Liu ZD; Aytemir MD; van der Helm D; Hider RC
Chemistry; 2010 Jun; 16(21):6374-81. PubMed ID: 20397153
[TBL] [Abstract][Full Text] [Related]
27. Deferiprone (L1) induced conformation change of hemoglobin: A fluorescence and CD spectroscopic study.
Chakraborty D; Bhattacharyya M
Mol Cell Biochem; 2000 Jan; 204(1-2):17-20. PubMed ID: 10718620
[TBL] [Abstract][Full Text] [Related]
28. Pharmaco/ferrokinetic-related pro-oxidant activity of deferiprone in beta-thalassemia.
Jirasomprasert T; Morales NP; Limenta LM; Sirijaroonwong S; Yamanont P; Wilairat P; Fucharoen S; Chantharaksri U
Free Radic Res; 2009 May; 43(5):485-91. PubMed ID: 19353420
[TBL] [Abstract][Full Text] [Related]
29. Characterization of two isomeric beta-d-glucosiduronic acids derived from 1,2-diethyl-3-hydroxypyridin-4-one (CP94) in rat liver homogenate incubates.
Liu DY; Liu ZD; Piyamongkol S; Lu SL; Hider RC
J Pharm Pharmacol; 2002 Jul; 54(7):951-7. PubMed ID: 12162714
[TBL] [Abstract][Full Text] [Related]
30. Deferiprone chelation therapy for thalassemia major.
Galanello R; Campus S
Acta Haematol; 2009; 122(2-3):155-64. PubMed ID: 19907153
[TBL] [Abstract][Full Text] [Related]
31. Complexation of iron with the orally active decorporation drug L1 (3-hydroxy-1,2-dimethyl-4-pyridinone).
Kline MA; Orvig C
Clin Chem; 1992 Apr; 38(4):562-5. PubMed ID: 1568323
[TBL] [Abstract][Full Text] [Related]
32. Deferiprone as an oral iron chelator in sickle cell disease.
Voskaridou E; Douskou M; Terpos E; Stamoulakatou A; Meletis J; Ourailidis A; Papassotiriou I; Loukopoulos D
Ann Hematol; 2005 Jul; 84(7):434-40. PubMed ID: 15809885
[TBL] [Abstract][Full Text] [Related]
33. Long-term treatment with deferiprone in a L1 veteran.
Meo A; Ruggeri A; La Rosa MA; Zanghì L; Kordes U; Fischer R
Eur J Haematol; 2005 Jun; 74(6):523-5. PubMed ID: 15876257
[TBL] [Abstract][Full Text] [Related]
34. Oral iron chelators.
Cappellini MD; Pattoneri P
Annu Rev Med; 2009; 60():25-38. PubMed ID: 19630568
[TBL] [Abstract][Full Text] [Related]
35. Iron chelation therapy.
Hoffbrand AV; Wonke B
J Intern Med Suppl; 1997; 740():37-41. PubMed ID: 9350180
[TBL] [Abstract][Full Text] [Related]
36. The safety, tolerability, and efficacy of a liquid formulation of deferiprone in young children with transfusional iron overload.
ElAlfy MS; Sari TT; Lee CL; Tricta F; El-Beshlawy A
J Pediatr Hematol Oncol; 2010 Nov; 32(8):601-5. PubMed ID: 20921906
[TBL] [Abstract][Full Text] [Related]
37. Effects of deferasirox and deferiprone on cellular iron load in the human hepatoma cell line HepaRG.
Gaboriau F; Leray AM; Ropert M; Gouffier L; Cannie I; Troadec MB; Loréal O; Brissot P; Lescoat G
Biometals; 2010 Apr; 23(2):231-45. PubMed ID: 19997770
[TBL] [Abstract][Full Text] [Related]
38. Comparative study of iron mobilization from haemosiderin, ferritin and iron(III) precipitates by chelators.
Kontoghiorghes GJ; Chambers S; Hoffbrand AV
Biochem J; 1987 Jan; 241(1):87-92. PubMed ID: 3566714
[TBL] [Abstract][Full Text] [Related]
39. The fenton activity of iron(III) in the presence of deferiprone.
Devanur LD; Neubert H; Hider RC
J Pharm Sci; 2008 Apr; 97(4):1454-67. PubMed ID: 17724662
[TBL] [Abstract][Full Text] [Related]
40. Potentiometric, spectrophotometric and calorimetric study on iron(III) and copper(II) complexes with 1,2-dimethyl-3-hydroxy-4-pyridinone.
Nurchi VM; Crisponi G; Pivetta T; Donatoni M; Remelli M
J Inorg Biochem; 2008 Apr; 102(4):684-92. PubMed ID: 18061272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
